review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.PNPBP.2004.05.027 |
P8608 | Fatcat ID | release_5d4ktujo6ndwhazsp6gqxn4eva |
P698 | PubMed publication ID | 15363608 |
P2093 | author name string | Harold Kalant | |
P433 | issue | 5 | |
P921 | main subject | effects of cannabis | Q4358078 |
P304 | page(s) | 849-863 | |
P577 | publication date | 2004-08-01 | |
P1433 | published in | Progress in Neuro-Psychopharmacology & Biological Psychiatry | Q15616665 |
P1476 | title | Adverse effects of cannabis on health: an update of the literature since 1996. | |
P478 | volume | 28 |
Q33938583 | A brief, web-based personalized feedback selective intervention for college student marijuana use: a randomized clinical trial |
Q36420881 | A polymorphism in the gene of the endocannabinoid-degrading enzyme FAAH (FAAH C385A) is associated with emotional-motivational reactivity |
Q37381180 | A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence |
Q47219944 | A prospective observational study of problematic oral cannabinoid use. |
Q36314660 | Acute intoxication caused by a synthetic cannabinoid in two adolescents |
Q37305934 | Adolescent cannabis problems and young adult depression: male-female stratified propensity score analyses. |
Q24644380 | Adverse effects of medical cannabinoids: a systematic review |
Q51893408 | Affect dysregulation in cannabis abusers: a study in adolescents and young adults. |
Q37497649 | Alcohol use potentiates marijuana problem severity in young adult women |
Q34588703 | An exploratory prospective study of marijuana use and mortality following acute myocardial infarction |
Q58914575 | Assessing topographical orientation skills in cannabis users |
Q39245884 | Association of herbal cannabis use with negative psychosocial parameters in patients with fibromyalgia |
Q34251969 | Blurred boundaries: the therapeutics and politics of medical marijuana |
Q46979193 | Brain imaging study of the acute effects of Delta9-tetrahydrocannabinol (THC) on attention and motor coordination in regular users of marijuana |
Q46729201 | Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in guinea-pig vessels, but not in rat and mouse aorta |
Q39004651 | Cannabinoids in the Management of Musculoskeletal or Rheumatic Diseases |
Q45857211 | Cannabis and traffic collision risk: findings from a case-crossover study of injured drivers presenting to emergency departments |
Q38170324 | Cannabis use: a perspective in relation to the proposed UK drug-driving legislation. |
Q36287890 | Cannabis, Cigarettes, and Their Co-Occurring Use: Disentangling Differences in Gray Matter Volume |
Q46912552 | Cannabis-Related treatment demands in Belgium: a socio-demographic and treatment seeking profile. |
Q80805114 | Cannabis; adverse effects from an oromucosal spray |
Q38011117 | Clinical implications for cannabinoid use in the rheumatic diseases: potential for help or harm? |
Q59382548 | Creencias y motivos asociados al consumo de cannabis en población escolarizada de la ciudad de Valencia, España |
Q43685054 | Cycling-related crash risk and the role of cannabis and alcohol: a case-crossover study |
Q37105603 | Decrease in adolescent cannabis use from 2002 to 2006 and links to evenings out with friends in 31 European and North American countries and regions |
Q43013037 | Do antisocial females exhibit poor outcomes in adulthood? An Australian cohort study. |
Q80247296 | Drugs and driving: when science and policy don't mix |
Q33608192 | Effectiveness of a marijuana expectancy manipulation: Piloting the balanced-placebo design for marijuana |
Q36672926 | Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences |
Q37441356 | Effects of research setting on observed depressive symptoms in marijuana users |
Q33906178 | Emergence of new classes of recreational drugs-synthetic cannabinoids and cathinones |
Q37710989 | Emerging issues for our nation's health: the intersection of marijuana use and cardiometabolic disease risk |
Q36912778 | Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain |
Q38185071 | Endocannabinoids and neuropathic pain: focus on neuron-glia and endocannabinoid-neurotrophin interactions |
Q46912506 | Evidence-based prevention of cannabis use in flanders is there a role for health economic evaluation? |
Q44462720 | Examination of the role of the combination of alcohol and cannabis in South Australian road crashes |
Q37437905 | Interest in marijuana treatment programs among teenage smokers and nonsmokers |
Q37564378 | Latent classes of substance use in adolescent cannabis users: predictors and subsequent substance-related harm |
Q45031827 | Long-term voluntary consumption of MDMA and THC in rats is modified by individual and situational factors |
Q36863880 | Longitudinal associations between social anxiety symptoms and cannabis use throughout adolescence: the role of peer involvement |
Q37949991 | Lower Risk Cannabis use Guidelines for Canada (LRCUG): a narrative review of evidence and recommendations. |
Q37142074 | Managing neuropathic pain with Sativex: a review of its pros and cons |
Q37002827 | Marijuana neurobiology and treatment |
Q35417708 | Marijuana use and tobacco smoking cessation among heavy alcohol drinkers |
Q21090461 | Marijuana: current concepts(†) |
Q36908774 | Measuring Protective Behavioral Strategies for Marijuana Use Among Young Adults. |
Q42785502 | Medical cannabis and chronic opioid therapy |
Q39971148 | Nabilone produces marked impairments to cognitive function and changes in subjective state in healthy volunteers. |
Q35638979 | Neuropsychological sex differences associated with age of initiated use among young adult cannabis users |
Q40202511 | New medical marijuana regulations: the coming storm |
Q92627340 | Opportunities for cannabis in supportive care in cancer |
Q47566397 | Perspectives of cannabis use in the life experience of men with schizophrenia |
Q34635342 | Pharmacological interventions in the treatment of the acute effects of cannabis: a systematic review of literature |
Q58163582 | Predictors of intention not to use cannabis among young adults who attend adult education centers |
Q42476002 | Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring |
Q30842208 | Psychosocial correlates of adolescent cannabis use: data from the Italian subsample of the second International Self-Reported Delinquency study. |
Q35928133 | Repeated cannabinoid administration increases indices of noradrenergic activity in rats |
Q26798333 | Safety and Toxicology of Cannabinoids |
Q34021470 | Screening and brief intervention to reduce marijuana use among youth and young adults in a pediatric emergency department |
Q43107556 | Self-reported collision risk associated with cannabis use and driving after cannabis use among Ontario adults |
Q37183987 | Social constructions of dependency by blunts smokers: Qualitative reports |
Q36698922 | Social identity as a moderator of the association between perceived norms and marijuana use. |
Q35124951 | Stigma among California's Medical Marijuana Patients |
Q38714523 | Substance use and misuse among children and youth with mental illness : A pilot study |
Q37335193 | Synthetic Cannabis Overdose and Withdrawal in a Young Adult: A Case Report, Commentary on Regulation, and Review of the Literature |
Q89861376 | Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain |
Q48082875 | The Formation of Marijuana Risk Perception in a Population of Substance Abusing Patients |
Q56970483 | The Initiation of Cannabis Use in Adolescence is Predicted by Sex-Specific Psychosocial and Neurobiological Features |
Q41285812 | The Protective Behavioral Strategies for Marijuana Scale: Further examination using item response theory |
Q42258328 | The Use of Cannabis for Headache Disorders |
Q35185234 | The association between early conduct problems and early marijuana use in college students |
Q38193035 | The dilemma of medical marijuana use by rheumatology patients |
Q36468298 | The occurrence of cannabis use disorders and other cannabis-related problems among first-year college students |
Q36150541 | The safety of cannabinoids for the treatment of multiple sclerosis |
Q33588821 | Typologies of cannabis users and associated characteristics relevant for public health: a latent class analysis of data from a nationally representative Canadian adult survey. |
Q91972249 | [Addictive behaviors: clinical facts] |
Q60723381 | Conduites addictives |
Search more.